Skip to main navigation

Investor Relations

About Us
Advanced Wound Care
Surgical & Sports Medicine
- NuCel
- ReNu
- NuShield
- Affinity
- FiberOS
- OCMP
- PuraPlyAM
Circle of Care Program
Reimbursement & Regulatory
- Reimbursement
- Regulatory
Patients
Professionals
- Medical Affairs
- Customer Service
Investors
Careers
News & Events
Contact Us

Press Releases

Press Releases

Search

Year

February 11, 2022

Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in February

CANTON, Mass., Feb. 11, 2022 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, today

February 7, 2022

Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2021 Financial Results on March 1, 2022

CANTON, Mass., Feb. 07, 2022 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today

Pagination

First page
Previous page
Page 1
Current page 2

Displaying 11 - 12 of 12

Shareholder Tools

Print

Print
Email

Email
RSS Feeds

RSS Feeds
Email Alerts

Email Alerts
Investor Contact

Investor Contact

© 2022 Organogenesis Holdings Inc. All rights reserved

About Us
Advanced Wound Care
Surgical and Sports Medicine
Circle of Care Program
Reimbursement and Regulatory

Connect with us

Patients
Professionals
Careers
Contact Us
terms of use
privacy policy
cookie policy